Who we are
Synpha Biosciences is creating a new generation of synthetic phage therapeutics to treat a wide variety of bacterial diseases. Using patent-protected technology and a novel machine learning AI platform, we build advanced therapeutics that overcome traditional hurdles in phage therapy.
We are a new company out of the University of Wisconsin-Madison and we are actively raising money to achieve our vision. If you would like to learn more, please contact us!